EyePoint Pharmaceuticals
Search documents
EyePoint Pharmaceuticals(EYPT) - 2020 Q2 - Quarterly Report
2020-08-05 11:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 000-51122 EyePoint Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorpo ...
EyePoint Pharmaceuticals(EYPT) - 2020 Q1 - Quarterly Report
2020-05-08 21:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 000-51122 EyePoint Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorp ...
EyePoint Pharmaceuticals(EYPT) - 2020 Q1 - Earnings Call Transcript
2020-05-06 18:02
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2020 Earnings Conference Call May 6, 2020 8:30 AM ET Company Participants George Elston - Chief Financial Officer and Head-Corporate Development Nancy Lurker - President and Chief Executive Officer Scott Jones - Chief Commercial Officer Dario Paggiarino - Senior Vice President and Chief Medical Officer Conference Call Participants I-Eh Jen - Laidlaw & Company Andrew D'Silva - B. Riley FBR Yi Chen - H.C. Wainwright Operator Good morning. My name is Shannon and ...
EyePoint Pharmaceuticals(EYPT) - 2019 Q4 - Earnings Call Transcript
2020-03-05 20:18
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2019 Earnings Conference Call March 5, 2020 8:30 AM ET Company Participants George Elston – Chief Financial Officer and Head-Corporate Development Nancy Lurker – President and Chief Executive Officer Scott Jones – Chief Commercial Officer Dario Paggiarino – Senior Vice President and Chief Medical Officer Conference Call Participants Dana Flanders – Guggenheim Securities Andrew D'Silva – B. Riley FBR I-Eh Jen – Laidlaw & Company Yi Chen – H.C. Wainwright Operat ...